By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Apr 16, 2020/Perspective
Was it more harmful to keep the doors open or close them?
Sep 2, 2025/Podcast
Listening Time — 9:17 Listen on Apple Listen on Castbox Listen on Spotify At the APTA Combined Sections Meeting in February 2025, students got a chance to ask questions and get advice from section leaders. In this installment, Jason Lau, PT, DPT, interviews Jamie Grigsby, PT, DPT, and Melissa Lazinski,
Feb 11, 2021/CPG
These updated guidelines address the prevention and management of pressure injuries in people with spinal cord injury, both in a Canadian context and globally.
Oct 1, 2014/CPG
Identifies adult patient groups at risk of venous thromboembolism and describes the available methods of prophylaxis, with general recommendations about efficacy, safety, and how they should be used.
Jan 1, 2019/CPG
These guidelines from the American Academy of Pediatric Dentistry (AAPD) are intended to assist the practitioner in the recognition and diagnosis of temporomandibular disorder (TMD) and to identify possible treatment options.
Dec 10, 2025/Article
Nov. 29 marked the 50th anniversary of the Individuals with Disabilities Education Act, a groundbreaking federal law that ensures children with disabilities are entitled to a free appropriate public education and that they receive related services, such as physical therapy, when needed. Under IDEA Part
Oct 22, 2018/News
The 2019 APTA CSM, set for January 23-26 in downtown Washington, DC, includes multiple sessions that go beyond the wow factor of technology and gets to practical applications in the clinic.
Sep 29, 2019/Perspective
As students, our voices are heard and collectively we can make a difference.
Apr 1, 2024/CPG
This guideline was created by the American College of Chest Physicians and Canadian Thoracic Society to help clinicians and patients gauge the appropriate use of cannabinoid-based medicines in the management of chronic pain and co-concurring conditions.
Denials happen. So do successful appeals.